{"id":"antifungal-treatment","safety":{"commonSideEffects":[{"rate":null,"effect":"Hepatotoxicity"},{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Infusion-related reactions"},{"rate":null,"effect":"Gastrointestinal disturbances"}]},"_chembl":{"chemblId":"CHEMBL7257","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":{"setId":"4dbbf09b-5bc1-501b-e063-6394a90a2a9d","title":"HERMON JOCK ITCH ANTIFUNGAL TREATMENT .SOAP. BAR (TOLNAFTATE 1%) SOAP [BEAUTIVITY LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Antifungals target structures and processes unique to fungi, such as ergosterol in the fungal cell membrane (disrupted by azoles and polyenes) or fungal cell wall components like beta-glucans (targeted by echinocandins). By interfering with these critical fungal-specific structures, antifungals either cause cell lysis and death or prevent fungal replication, allowing the immune system to clear the infection.","oneSentence":"Antifungal treatments work by disrupting fungal cell wall or membrane integrity, or inhibiting essential fungal enzymes, thereby killing or stopping the growth of fungal organisms.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T04:10:36.442Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Fungal infections (specific indication depends on formulation and active ingredient)"}]},"trialDetails":[{"nctId":"NCT06925321","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2025-08-26","conditions":"Invasive Mold Infections","enrollment":219},{"nctId":"NCT05780879","phase":"PHASE2","title":"A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia","status":"SUSPENDED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2024-06-03","conditions":"Secondary Acute Myeloid Leukemia","enrollment":20},{"nctId":"NCT07471178","phase":"PHASE4","title":"Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor","status":"NOT_YET_RECRUITING","sponsor":"Fakultas Kedokteran Universitas Indonesia","startDate":"2026-02","conditions":"Pityriasis Versicolor","enrollment":76},{"nctId":"NCT05256641","phase":"PHASE1, PHASE2","title":"Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma","status":"RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2023-01-23","conditions":"Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma, Transformed Lymphoma","enrollment":24},{"nctId":"NCT00748345","phase":"PHASE2, PHASE3","title":"Pharmacokinetics of Caspofungin in Burn Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-02","conditions":"Thermal Injury","enrollment":2},{"nctId":"NCT07243483","phase":"NA","title":"Study of the Relationship Between the Pharmacokinetics (PK) and Pharmacodynamics of Venetoclax in Patients With Acute Myeloblastic Leukemia","status":"RECRUITING","sponsor":"Centre Leon Berard","startDate":"2026-01-21","conditions":"Acute Myeloid Leukemia","enrollment":100},{"nctId":"NCT07283094","phase":"PHASE1","title":"FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-02-03","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":33},{"nctId":"NCT06356311","phase":"PHASE3","title":"A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-05-03","conditions":"Gastroesophageal Cancer","enrollment":450},{"nctId":"NCT04966585","phase":"PHASE4","title":"Pilot Study of Posaconazole in Crohn's Disease","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-08-17","conditions":"Crohn Disease, CARD9 S12N Risk Allele","enrollment":10},{"nctId":"NCT06637423","phase":"PHASE1, PHASE2","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-12-20","conditions":"Non-Muscle Invasive Bladder Cancer","enrollment":32},{"nctId":"NCT07420894","phase":"NA","title":"Comparison of Combination of Itraconazole and Isotretinoin Versus Itraconazole Alone in the Treatment of Resistant Trichophyton Infection","status":"COMPLETED","sponsor":"Multan Medical And Dental College","startDate":"2025-01-29","conditions":"Dermatophytosis, Trichophyton Infection, Resistant Dermatophyte Infection","enrollment":148},{"nctId":"NCT04368559","phase":"PHASE3","title":"Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mundipharma Research Limited","startDate":"2020-05-11","conditions":"Candidemia, Mycoses, Fungal Infection","enrollment":602},{"nctId":"NCT07215273","phase":"PHASE2","title":"Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections","status":"RECRUITING","sponsor":"Elion Therapeutics, Inc.","startDate":"2026-02","conditions":"Suspected Invasive Mould Infection","enrollment":80},{"nctId":"NCT05110001","phase":"PHASE3","title":"Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2022-08-03","conditions":"Acanthamoeba Keratitis, Fungal Keratitis","enrollment":330},{"nctId":"NCT07362667","phase":"","title":"A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA","status":"RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2026-01-10","conditions":"ABPA, Allergic Bronchopulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis (ABPA)","enrollment":44},{"nctId":"NCT07357038","phase":"","title":"A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-09-30","conditions":"Fungal Disease","enrollment":38},{"nctId":"NCT05238116","phase":"PHASE3","title":"Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study)","status":"TERMINATED","sponsor":"Pulmocide Ltd","startDate":"2022-06-14","conditions":"Refractory IPA","enrollment":85},{"nctId":"NCT07342153","phase":"PHASE4","title":"Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis","status":"RECRUITING","sponsor":"Urooj Fatima","startDate":"2025-11-01","conditions":"Tinea Corporis, Dermatophytosis","enrollment":126},{"nctId":"NCT07337720","phase":"NA","title":"Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Southeast University, China","startDate":"2025-12-20","conditions":"Aspergillosis Invasive","enrollment":40},{"nctId":"NCT07333170","phase":"PHASE4","title":"Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor.","status":"NOT_YET_RECRUITING","sponsor":"PAEC General Hospital, Islamabad","startDate":"2026-02","conditions":"Pityriasis Versicolor","enrollment":86},{"nctId":"NCT06970262","phase":"NA","title":"FMT for Lung and Associated-organ Rescue Efficacy in Pulmonary Infection With MDROs","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-05-20","conditions":"Lung Infection, Microbial Colonization, Food Intolerance Syndromes","enrollment":150},{"nctId":"NCT06666322","phase":"PHASE2, PHASE3","title":"Platform Trial For Cryptococcal Meningitis","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2025-05-28","conditions":"Hiv, Cryptococcal Meningitis","enrollment":2000},{"nctId":"NCT05101187","phase":"PHASE3","title":"Olorofim Aspergillus Infection Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"F2G Biotech GmbH","startDate":"2022-03-31","conditions":"Invasive Aspergillosis","enrollment":225},{"nctId":"NCT07311759","phase":"PHASE3","title":"Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-08-17","conditions":"Chronic Paronychia","enrollment":21},{"nctId":"NCT03774316","phase":"","title":"De-escalation - Antifungal Treatment Immunocompromised Patients","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2019-01-28","conditions":"Invasive Fungal Disease, Critical Illness","enrollment":275},{"nctId":"NCT02154178","phase":"NA","title":"Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2014-07","conditions":"Fungal Infection, Critical Illness","enrollment":110},{"nctId":"NCT07295314","phase":"EARLY_PHASE1","title":"Effect of Antifungals on the Intestinal Microbiome - a Randomized, Controlled, Proof-of-concept Trial","status":"NOT_YET_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2026-01","conditions":"Gut Microbiome, Healthy Adult Male, Antifungal Therapy","enrollment":50},{"nctId":"NCT03013998","phase":"PHASE1, PHASE2","title":"Study of Biomarker-Based Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Beat AML, LLC","startDate":"2016-11","conditions":"Previously Untreated Relapsed Refractory Acute Myeloid Leukemia","enrollment":3000},{"nctId":"NCT02805049","phase":"PHASE4","title":"Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study)","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2017-01-28","conditions":"Septic Shock, Peritonitis","enrollment":24},{"nctId":"NCT07245667","phase":"PHASE2","title":"Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study","status":"RECRUITING","sponsor":"Propedix, Inc.","startDate":"2024-12-30","conditions":"Tinea Pedis","enrollment":150},{"nctId":"NCT07238686","phase":"PHASE2","title":"Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS","status":"RECRUITING","sponsor":"Beijing 302 Hospital","startDate":"2025-06-20","conditions":"Myelodysplastic Syndromes","enrollment":40},{"nctId":"NCT07242703","phase":"NA","title":"Efficacy of Ultraviolet B Phototherapy in the Management of Resistant and Relapsing Tinea Corporis and Tinea Cruris","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-12-01","conditions":"Fungal Resistance","enrollment":36},{"nctId":"NCT02955966","phase":"NA","title":"PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-02","conditions":"Aspergillosis and Haematological Malignancy","enrollment":51},{"nctId":"NCT06285188","phase":"","title":"Immunomonitoring of Mold Invasive Infections","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-07-28","conditions":"Invasive Fungal Disease, Mold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium","enrollment":20},{"nctId":"NCT07169357","phase":"EARLY_PHASE1","title":"Testing the Efficacy of Photobiomodulation Therapy and Hyaluronic Acid Gel on Post-surgical Healing After Gingivectomy","status":"ENROLLING_BY_INVITATION","sponsor":"Beirut Arab University","startDate":"2025-11-11","conditions":"Gingival Hyperplasia, Gingival Hypertrophy, Gingival Overgrowth","enrollment":38},{"nctId":"NCT06774144","phase":"PHASE3","title":"Rezafungin Prophylaxis in Liver Transplant","status":"ENROLLING_BY_INVITATION","sponsor":"Fernanda P Silveira, MD, MS","startDate":"2025-10-15","conditions":"Liver Transplant Infection, Fungal Infection","enrollment":385},{"nctId":"NCT07204522","phase":"","title":"Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-09-22","conditions":"Febrile Neutropenia","enrollment":20},{"nctId":"NCT07152327","phase":"NA","title":"Terbinafine Hydrochloride for the Treatment of Otomycosis","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-10-01","conditions":"Otomycosis, Fungal Ear Infection","enrollment":50},{"nctId":"NCT07185503","phase":"","title":"Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-03-25","conditions":"Mucormycosis in Hematologic Malignancies","enrollment":60},{"nctId":"NCT05961839","phase":"PHASE1","title":"Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome","status":"TERMINATED","sponsor":"Schrödinger, Inc.","startDate":"2023-09-27","conditions":"Acute Myeloid Leukemia, High-Risk and Very High-Risk Myelodysplastic Syndromes","enrollment":66},{"nctId":"NCT03604705","phase":"PHASE2","title":"An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia","status":"COMPLETED","sponsor":"Basilea Pharmaceutica","startDate":"2018-10-03","conditions":"Candidemia","enrollment":21},{"nctId":"NCT02145832","phase":"PHASE2, PHASE3","title":"Fluconazole Versus Micafungin in Neonates With Candidiasis","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2014-10","conditions":"Candidiasis","enrollment":100},{"nctId":"NCT07135778","phase":"","title":"Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Patients With Malignant Hematological Diseases","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-05-19","conditions":"Invasive Fungal Disease","enrollment":36},{"nctId":"NCT06300138","phase":"NA","title":"Antifungal Agents and Infrared Thermotherapy Alone or in Combination in the Treatment of Sporotrichosis","status":"RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2024-03-15","conditions":"Sporotrichosis","enrollment":150},{"nctId":"NCT07084584","phase":"PHASE1, PHASE2","title":"An Open-label, Dose-Escalation and Dose-Expansion Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Galecto Biotech AB","startDate":"2026-06-10","conditions":"Relapsed/Refractory Acute Myeloid Leukemia (AML)","enrollment":184},{"nctId":"NCT07082621","phase":"NA","title":"N Acetylcystene in Treatment of Radiotherapy Induced Oral Mucositis in Oral Cancer Patients","status":"COMPLETED","sponsor":"Hams Hamed Abdelrahman","startDate":"2024-01-15","conditions":"Oral Mucositis","enrollment":40},{"nctId":"NCT07080359","phase":"","title":"Isavuconazole in Critically Ill Patients: Efficacy and Safety","status":"NOT_YET_RECRUITING","sponsor":"Shanghai 10th People's Hospital","startDate":"2025-08-01","conditions":"Fungal Infection, Aspergillosis, Mucormycosis","enrollment":75},{"nctId":"NCT07073092","phase":"PHASE2","title":"Propolis for Management of Chemotherapy-Induced Oral Mucositis in Pediatric Patients","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2025-07-15","conditions":"Oral Mucositis Due to Chemotherapy","enrollment":50},{"nctId":"NCT07069933","phase":"PHASE2","title":"Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2025-07","conditions":"Acute Myeloid Leukemia","enrollment":50},{"nctId":"NCT04157465","phase":"NA","title":"Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-11-07","conditions":"Antifungal Agents, Invasive Fungal Infections, Mycoses","enrollment":216},{"nctId":"NCT05739682","phase":"NA","title":"Pain and Microbial Reduction of Antimicrobial Corticosteroid Mixture Versus Cryotherapy in Necrotic Teeth","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-07-01","conditions":"Dental Pulp Necrosis","enrollment":28},{"nctId":"NCT06789588","phase":"PHASE3","title":"Protocol for Improvement of Therapy With Warfarin","status":"ENROLLING_BY_INVITATION","sponsor":"University of Pernambuco","startDate":"2024-10-21","conditions":"Atrial Fibrillation (AF)","enrollment":700},{"nctId":"NCT05426499","phase":"","title":"Translational PKPD Modeling of Anti-infective Drugs Used in Pediatric Units.","status":"RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2021-10-01","conditions":"Population Modeling of Anti-infective Drugs","enrollment":150},{"nctId":"NCT06967376","phase":"EARLY_PHASE1","title":"The Role of Adjuvant Corneal Crosslinking in the Management of Infective Keratitis","status":"COMPLETED","sponsor":"Research Institute of Ophthalmology, Egypt","startDate":"2018-05-21","conditions":"Infective Keratitis","enrollment":40},{"nctId":"NCT05763251","phase":"NA","title":"Comparison of Uncomplicated Candidemia Therapy Duration in Children","status":"RECRUITING","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2023-09-08","conditions":"Invasive Candidiasis","enrollment":420},{"nctId":"NCT06926569","phase":"NA","title":"Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Public Health Clinical Center","startDate":"2025-05-01","conditions":"HIV/AIDS-associated Talaromycosis","enrollment":116},{"nctId":"NCT01969786","phase":"NA","title":"Village Integrated Eye Workers Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2014-02","conditions":"Corneal Ulcer","enrollment":223671},{"nctId":"NCT05534529","phase":"PHASE1","title":"Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age","status":"TERMINATED","sponsor":"Mundipharma Research Limited","startDate":"2023-09-13","conditions":"Invasive Fungal Infections","enrollment":32},{"nctId":"NCT06907992","phase":"","title":"A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia","status":"NOT_YET_RECRUITING","sponsor":"Augusta University","startDate":"2025-05-01","conditions":"Candidemia","enrollment":150},{"nctId":"NCT06892951","phase":"PHASE1, PHASE2","title":"CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Tours","startDate":"2025-06","conditions":"Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection, Pneumocystis Infections","enrollment":100},{"nctId":"NCT06862817","phase":"PHASE1, PHASE2","title":"Comparison Between the Effect of Aloe Vera and Benzydamine Hydrochloride Mouth Gel on Prevention of Pain and Progression of Radiation-induced Oral Mucositis","status":"COMPLETED","sponsor":"Minia University","startDate":"2023-11-01","conditions":"Radiation Indused Oral Mucositis","enrollment":30},{"nctId":"NCT06859671","phase":"PHASE3","title":"A Randomized Study of a Short Duration Therapy for Candidemia","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-07-01","conditions":"CANDIDEMIA","enrollment":362},{"nctId":"NCT05653193","phase":"PHASE2","title":"Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study","status":"RECRUITING","sponsor":"Manchester University NHS Foundation Trust","startDate":"2024-05-17","conditions":"Chronic Pulmonary Aspergillosis, Aspergillosis","enrollment":50},{"nctId":"NCT04461821","phase":"","title":"Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents","status":"RECRUITING","sponsor":"University Children's Hospital Basel","startDate":"2020-09-11","conditions":"Respiratory Diseases, Neurological Disorders, Type 1 Diabetes","enrollment":3600},{"nctId":"NCT06835361","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis","status":"RECRUITING","sponsor":"AVVA Pharmaceuticals Ltd.","startDate":"2024-02-29","conditions":"Candidal Vulvovaginitis (ICD-10 Code: B37.3), Vulvovaginal Candidiasis (VVC)","enrollment":264},{"nctId":"NCT06819410","phase":"","title":"Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2021-05-01","conditions":"Invasive Fungal Disease","enrollment":1000},{"nctId":"NCT06681090","phase":"PHASE1","title":"Different Treatment Modalities for Oral Lichen Plan","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2023-03-03","conditions":"Oral Lichen Planus","enrollment":20},{"nctId":"NCT06779370","phase":"NA","title":"Effect of Calcium Silicate-Based Root Canal Medicament After Retreatment","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2024-06-12","conditions":"Antibacterial Agents, Postoperative Dental Pain, Antifungal Agents","enrollment":60},{"nctId":"NCT01566695","phase":"PHASE3","title":"The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)","status":"COMPLETED","sponsor":"Celgene","startDate":"2013-04-26","conditions":"Myelodysplastic Syndrome","enrollment":216},{"nctId":"NCT06759766","phase":"NA","title":"Evaluation of Antimicrobial Potency of Garlic Lemon Extract Irrigant Versus Physiological Saline Irrigant","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-01-01","conditions":"Necrotic Primary Teeth","enrollment":38},{"nctId":"NCT06757179","phase":"NA","title":"The ELYAR (Elysium Against Rhinitis) Project","status":"COMPLETED","sponsor":"Federico II University","startDate":"2023-12-01","conditions":"Rhinitis Viral","enrollment":60},{"nctId":"NCT06756191","phase":"PHASE4","title":"Antifungal Drugs in Pulmonary Mucormycosis","status":"NOT_YET_RECRUITING","sponsor":"Bin Cao","startDate":"2025-01-10","conditions":"Pulmonary Mucormycosis","enrollment":312},{"nctId":"NCT06583512","phase":"","title":"Treatment Duration of IPA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-12-01","conditions":"Invasive Aspergillosis, Antifungal Therapy","enrollment":15},{"nctId":"NCT04925388","phase":"NA","title":"Impact of Rapid Molecular Diagnostic Method on Antibiotics Exposure Duration in ICU Patients with Postoperative Peritonitis","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-12-30","conditions":"Postoperative Peritonitis","enrollment":16},{"nctId":"NCT03318159","phase":"PHASE2","title":"Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2018-04-20","conditions":"Aplastic Anemia, Myelodysplastic Syndromes, Fungal Infection","enrollment":20},{"nctId":"NCT04979052","phase":"PHASE2","title":"Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2022-03-31","conditions":"Candidemia","enrollment":200},{"nctId":"NCT02646774","phase":"PHASE4","title":"Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis","status":"TERMINATED","sponsor":"Astellas Pharma China, Inc.","startDate":"2014-03-01","conditions":"Invasive Aspergillosis","enrollment":43},{"nctId":"NCT03059992","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment","status":"COMPLETED","sponsor":"Scynexis, Inc.","startDate":"2017-04-01","conditions":"Invasive Candidiasis, Mucocutaneous Candidiasis, Coccidioidomycosis","enrollment":233},{"nctId":"NCT03421002","phase":"PHASE2","title":"Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2015-05-30","conditions":"Candidiasis, Systemic, Candida Meningitis","enrollment":35},{"nctId":"NCT06362642","phase":"PHASE1","title":"A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of PC14586 in Healthy Participants","status":"COMPLETED","sponsor":"PMV Pharmaceuticals, Inc","startDate":"2024-03-28","conditions":"Healthy Volunteers","enrollment":12},{"nctId":"NCT06680544","phase":"PHASE2","title":"Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections","status":"NOT_YET_RECRUITING","sponsor":"Sheikh Zayed Medical College","startDate":"2024-11-15","conditions":"Dermatophyte Infection","enrollment":120},{"nctId":"NCT01686607","phase":"","title":"Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2012-10-01","conditions":"Systemic Fungal Infections","enrollment":40110},{"nctId":"NCT02127788","phase":"","title":"Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology","status":"COMPLETED","sponsor":"Astellas Pharma S.A.S.","startDate":"2014-07-03","conditions":"Antifungal Prophylaxis, Haemopathy","enrollment":150},{"nctId":"NCT06616168","phase":"PHASE1","title":"Urogenital Infections in Women of Reproductive Age and the Activity of 4-Thiazolidinone Derivatives Against Pathogens","status":"ACTIVE_NOT_RECRUITING","sponsor":"Danylo Halytsky Lviv National Medical University","startDate":"2023-09-01","conditions":"Bacterial Vaginosis","enrollment":200},{"nctId":"NCT03090334","phase":"NA","title":"A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis","status":"TERMINATED","sponsor":"University of Bologna","startDate":"2017-03-01","conditions":"Invasive Candidiases, Abdominal Infection","enrollment":34},{"nctId":"NCT02907359","phase":"PHASE3","title":"Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs","status":"COMPLETED","sponsor":"Astex Pharmaceuticals, Inc.","startDate":"2017-01-13","conditions":"Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic","enrollment":417},{"nctId":"NCT04847050","phase":"PHASE2","title":"A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2021-04-28","conditions":"Solid Tumor Malignancy, Hematologic Malignancy, Leukemia","enrollment":19},{"nctId":"NCT05452668","phase":"NA","title":"Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients","status":"UNKNOWN","sponsor":"Children's Cancer Hospital Egypt 57357","startDate":"2023-05-16","conditions":"Oral Mucositis, Childhood Acute Lymphoblastic Leukemia","enrollment":51},{"nctId":"NCT06562621","phase":"PHASE1, PHASE2","title":"Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma","status":"COMPLETED","sponsor":"Beijing Neurosurgical Institute","startDate":"2018-08-01","conditions":"Glioblastoma Multiforme, Gliomas, Malignant","enrollment":38},{"nctId":"NCT06535126","phase":"PHASE1","title":"Safety and Tolerability Studies of CanProFem-AK, Vaginal Suppositories in Healthy Volunteers","status":"COMPLETED","sponsor":"Industrial Microbiology LLP","startDate":"2024-06-01","conditions":"Candidosis Vaginal","enrollment":20},{"nctId":"NCT04874441","phase":"NA","title":"Candida PCR Diagnosis Strategy in Patients From Intensive Care Units","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2022-05-19","conditions":"Candida","enrollment":120},{"nctId":"NCT06533033","phase":"NA","title":"Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hams Hamed Abdelrahman","startDate":"2024-01-01","conditions":"Oral Lichen Planus","enrollment":50},{"nctId":"NCT06495905","phase":"NA","title":"Efficacy and Safety of Systematic Therapy and Bronchoscopic Interventional Treatment for Pulmonary Mucormycosis","status":"UNKNOWN","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2024-07-30","conditions":"Pulmonary Mucormycosis","enrollment":30},{"nctId":"NCT03580733","phase":"PHASE3","title":"Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2019-01-01","conditions":"ICU Yeast Intra-abdominal Infection","enrollment":448},{"nctId":"NCT06485050","phase":"NA","title":"Photodynamic Therapy and Topical Antifungal for Onychomycosis in Patients With Diabetes.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universidad Complutense de Madrid","startDate":"2024-04-17","conditions":"Dermatologic Disease, Onychomycosis of Toenail, Diabetic Foot","enrollment":10},{"nctId":"NCT05279846","phase":"PHASE3","title":"A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Moberg Pharma AB","startDate":"2022-05-09","conditions":"Onychomycosis","enrollment":350},{"nctId":"NCT05049525","phase":"PHASE2","title":"Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease","status":"TERMINATED","sponsor":"Montreal Heart Institute","startDate":"2022-02-22","conditions":"Crohn's Disease, Inflammatory Bowel Diseases","enrollment":16},{"nctId":"NCT03538912","phase":"NA","title":"Early Discontinuation of Empirical Antifungal Therapy and Biomarkers","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2018-06-06","conditions":"Invasive Candidiasis","enrollment":194},{"nctId":"NCT05482763","phase":"","title":"Mycosis Culture Collection From Dermatological Isolated","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Rome Tor Vergata","startDate":"2022-07-20","conditions":"Onychomycosis, Resistant Infection, Nail Diseases","enrollment":200},{"nctId":"NCT06400056","phase":"PHASE1","title":"Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-05","conditions":"Fungal Resistance","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Antifungal treatment","genericName":"Antifungal treatment","companyName":"Hospices Civils de Lyon","companyId":"hospices-civils-de-lyon","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antifungal treatments work by disrupting fungal cell wall or membrane integrity, or inhibiting essential fungal enzymes, thereby killing or stopping the growth of fungal organisms. Used for Fungal infections (specific indication depends on formulation and active ingredient).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}